Peptide Protocol BPHRT Research Dashboard
Protocol Active 12-Week
i

Research & Educational Use Only. This dashboard is for informational and reference purposes only. It does not constitute medical advice and does not replace the guidance of a licensed provider. Always follow your prescribed protocol.

BPHRT Research Dashboard

Peptide Protocol
12-Week Program

Complete supply tracking, reconstitution guide, dosage schedule, and handling instructions for two researchers across a full 12-week cycle.

12
Week Protocol
2
Researchers
4
Compounds
5
Dose Phases
Set your Week 1 start date in the calendar below to see today's prep guide.
My Dosing Calendar
Default start: Loading…
Set your Week 1 start date above to see your personalized dosing calendar
with exact doses and draw-up volumes for each day.
Tesamorelin Daily · mcg/day
CJC-1295 / Ipa 5 on / 2 off · mcg each
KLOW Daily · units
Retatrutide Weekly · mg
Inventory — Enter On-Hand Amounts
Researchers:
Tesamorelin
Standalone peptide
203mg
Protocol Total
10mg vials
qty
× 10mg = 120mg
12mg vials
qty
× 12mg = 12mg
CJC-1295 / Ipamorelin
5mg+5mg blend per vial
145mg
Protocol Total
10mg blend vials
qty
× 10mg = 20mg
6mg blend vials
qty
× 6mg = 6mg
KLOW
80mg blend per vial
728mg
Protocol Total
80mg vials
qty
× 80mg = 240mg
Retatrutide
GLP-1/GIP/glucagon agonist
96mg
Protocol Total
48mg vials
qty
× 48mg = 96mg
20mg vials
qty
× 20mg = 40mg
Supply Status — 2 Researchers
Peptide Total Needed Action
Tesamorelin
CJC/Ipa
KLOW
Retatrutide

Reorder by Week 3 to avoid protocol interruption.

Reconstitution Guide
  • Tesamorelin: 3.0 mL bacteriostatic water. Use reconstituted vial within 24–48 hours.

  • CJC-1295 / Ipamorelin: 3.0 mL bacteriostatic water. Administer 5 days ON / 2 days OFF.

  • KLOW (80mg): 3.0 mL bacteriostatic water. Stable for 14–28 days refrigerated.

  • Retatrutide (48mg): 4.8 mL bacteriostatic water — 10 units = 1 mg on U-100 syringe.

  • Retatrutide (20mg): 2.0 mL bacteriostatic water — 10 units = 1 mg on U-100 syringe.

Handling & Storage
  • Freeze Lyophilized: Keep powder at −20°C (−4°F) until reconstitution.
  • Refrigerate Liquid: Keep all reconstituted vials at 2–8°C (36–46°F).
  • Site Rotation: Rotate injection sites daily — abdomen, thighs, and upper arms.
  • Injection Technique: 45–90° angle, into subcutaneous tissue. Do not aspirate.
Research Supplies Needed
  • 400× Insulin Syringes (U-100, 1cc)
  • 15× Bacteriostatic Water (10 mL vials)
  • Alcohol Swab Boxes (100-count)
  • Approved Sharps Container